Jack Callahan serves as Executive Director, OTC Products at CME Group. He is responsible for leading the global go-to-market strategies for CME’s cleared OTC businesses.
Previously he served as Product Manager, Interest Rate Products, where he played a leading role in launching the company’s Interest Rate Swap clearing solution.
Prior to joining CME Group in 2009, Callahan most recently worked for Bank of America as a Derivative Marketer, where he was responsible for structuring and executing interest rate hedging strategies with the bank’s corporate, real estate and private wealth clients.
He holds a bachelor’s degree in finance from the University of Texas at Austin and an MBA from Harvard Business School.